Company Filing History:
Years Active: 2014-2016
Title: Terence John Kiesow: Innovator in Cancer Treatment
Introduction
Terence John Kiesow is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of cancer treatment through his innovative work. With a total of 2 patents, Kiesow has focused on developing compounds that target fatty acid synthase, a crucial enzyme in cancer cell metabolism.
Latest Patents
Kiesow's latest patents include the use of triazolone derivatives as fatty acid synthase inhibitors. This invention relates to the modulation, particularly the inhibition of the activity or function of fatty acid synthase (FAS). The present invention highlights the potential of triazolones in the treatment of cancer, showcasing their therapeutic promise.
Career Highlights
Throughout his career, Kiesow has been associated with GlaxoSmithKline LLC, where he has contributed to groundbreaking research and development in pharmaceuticals. His work has been instrumental in advancing the understanding of cancer treatment options.
Collaborations
Kiesow has collaborated with notable colleagues, including Nicholas D Adams and Christopher Joseph Aquino. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Terence John Kiesow's contributions to cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research in the field.